Nichols & Pratt Advisers LLP MA Makes New Investment in Waters Co. (NYSE:WAT)

Nichols & Pratt Advisers LLP MA acquired a new stake in Waters Co. (NYSE:WATFree Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 9,465 shares of the medical instruments supplier’s stock, valued at approximately $2,594,000.

Other large investors also recently modified their holdings of the company. Glassman Wealth Services boosted its holdings in shares of Waters by 39.6% in the 2nd quarter. Glassman Wealth Services now owns 141 shares of the medical instruments supplier’s stock worth $38,000 after acquiring an additional 40 shares in the last quarter. Private Trust Co. NA boosted its holdings in shares of Waters by 55.3% in the 3rd quarter. Private Trust Co. NA now owns 118 shares of the medical instruments supplier’s stock worth $32,000 after acquiring an additional 42 shares in the last quarter. Summit Trail Advisors LLC boosted its holdings in shares of Waters by 3.9% in the 3rd quarter. Summit Trail Advisors LLC now owns 1,180 shares of the medical instruments supplier’s stock worth $324,000 after acquiring an additional 44 shares in the last quarter. IFP Advisors Inc boosted its holdings in shares of Waters by 35.2% in the 3rd quarter. IFP Advisors Inc now owns 173 shares of the medical instruments supplier’s stock worth $47,000 after acquiring an additional 45 shares in the last quarter. Finally, Wetherby Asset Management Inc. boosted its holdings in shares of Waters by 2.9% in the 1st quarter. Wetherby Asset Management Inc. now owns 1,645 shares of the medical instruments supplier’s stock worth $511,000 after acquiring an additional 46 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Stock Performance

WAT opened at $322.82 on Monday. The business’s 50-day moving average price is $315.13 and its two-hundred day moving average price is $285.33. Waters Co. has a 1 year low of $231.90 and a 1 year high of $341.94. The company has a market capitalization of $19.09 billion, a price-to-earnings ratio of 29.75, a P/E/G ratio of 6.42 and a beta of 0.92. The company has a debt-to-equity ratio of 2.71, a current ratio of 0.69 and a quick ratio of 0.47.

Waters (NYSE:WATGet Free Report) last released its earnings results on Tuesday, February 6th. The medical instruments supplier reported $3.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.56 by $0.06. The business had revenue of $819.50 million for the quarter, compared to the consensus estimate of $815.50 million. Waters had a return on equity of 81.30% and a net margin of 21.72%. Waters’s quarterly revenue was down 4.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.84 earnings per share. Equities analysts expect that Waters Co. will post 11.89 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Barclays boosted their target price on Waters from $230.00 to $275.00 and gave the stock an “underweight” rating in a report on Thursday, January 25th. Citigroup upped their price objective on Waters from $265.00 to $300.00 and gave the stock a “neutral” rating in a report on Monday, December 11th. Stifel Nicolaus upped their price objective on Waters from $290.00 to $330.00 and gave the stock a “hold” rating in a report on Wednesday, February 7th. TheStreet upgraded shares of Waters from a “c+” rating to a “b-” rating in a research report on Wednesday, December 13th. Finally, Wells Fargo & Company dropped their target price on shares of Waters from $305.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 8th. One equities research analyst has rated the stock with a sell rating and eight have given a hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $290.38.

Read Our Latest Research Report on WAT

Waters Company Profile

(Free Report)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Stories

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.